Literature DB >> 16702830

Epidemiology and natural history of multiple sclerosis: new insights.

Orhun Kantarci1, Dean Wingerchuk.   

Abstract

PURPOSE OF REVIEW: The cause of multiple sclerosis remains elusive. We review recent epidemiological studies of genetic and environmental factors that influence susceptibility to the disease and its clinical course. RECENT
FINDINGS: Genetic advances strengthen the association of multiple sclerosis with the human leukocyte antigen (HLA)-DRB1 allele and interferon-gamma polymorphisms and suggest that apolipoprotein E alleles play an important role. In the environmental realm, nested case-control studies show that prior Epstein-Barr virus exposure is overrepresented in multiple sclerosis. Smoking has been associated with both risk of multiple sclerosis and progressive disease. Vitamin D deficiency might tie together environmental clues with higher multiple sclerosis prevalence rates; dietary vitamin supplementation is also associated with reduced multiple sclerosis risk. Natural history studies demonstrated dissociation between relapses and disease progression, facilitated the ability to distinguish neuromyelitis optica and related syndromes from typical multiple sclerosis, and spawned the exploration of large datasets to model long-term disease activity.
SUMMARY: Our understanding of the contributions of specific genetic and environmental factors that contribute to multiple sclerosis has improved. Further refinements will eventually allow powerful longitudinal studies to assess genetic and environmental interactions with implications for prediction of individual disease susceptibility, clinical course, and response to therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702830     DOI: 10.1097/01.wco.0000227033.47458.82

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  38 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 2.  Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

Authors:  Alexander Rae-Grant; Amy Bennett; Amy E Sanders; Michael Phipps; Eric Cheng; Christopher Bever
Journal:  Neurology       Date:  2015-09-02       Impact factor: 9.910

3.  Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.

Authors:  Khrishen Cunnusamy; Ethan J Baughman; Jorge Franco; Sterling B Ortega; Sushmita Sinha; Parul Chaudhary; Benjamin M Greenberg; Elliot M Frohman; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2014-03-20       Impact factor: 3.969

4.  Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life.

Authors:  Motahare Mokhtarzade; Rouholah Ranjbar; Nastaran Majdinasab; Darpan Patel; Mehdieh Molanouri Shamsi
Journal:  Endocrine       Date:  2017-06-14       Impact factor: 3.633

Review 5.  Genetics and pathogenesis of multiple sclerosis.

Authors:  R L Zuvich; J L McCauley; M A Pericak-Vance; J L Haines
Journal:  Semin Immunol       Date:  2009-09-22       Impact factor: 11.130

6.  Time of birth, residential solar radiation and age at onset of multiple sclerosis.

Authors:  Tzu-Yun McDowell; Sania Amr; Patricia Langenberg; Walter Royal; Christopher Bever; William J Culpepper; Douglas D Bradham
Journal:  Neuroepidemiology       Date:  2010-03-18       Impact factor: 3.282

7.  Perspectives on self-management in multiple sclerosis: a focus group study.

Authors:  Elizabeth S Knaster; Kathryn M Yorkston; Kurt Johnson; Kara A McMullen; Dawn M Ehde
Journal:  Int J MS Care       Date:  2011

8.  The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis.

Authors:  Jose Avila-Ornelas; Mirla Avila; Milena Stosic; Liliana Robles; Pilar Guillermo Prieto; George J Hutton; Victor M Rivera
Journal:  Int J MS Care       Date:  2011

9.  Downregulating DR6 to drive remyelination.

Authors:  Brian Popko
Journal:  Nat Med       Date:  2011-07-07       Impact factor: 53.440

10.  Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications.

Authors:  Shien Guo; Duygu Bozkaya; Alexandra Ward; Judith A O'Brien; Khajak Ishak; Randy Bennett; Ahmad Al-Sabbagh; Dennis M Meletiche
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.